Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Individualized Open Lung Ventilation and Postoperative Pulmonary Complications in Thoracic Surgery

This prospective, single-center, randomized controlled trial aims to evaluate the efficacy of an intraoperative "Individualized Open Lung Ventilation" strategy compared to a standard lung-protective ventilation strategy in patients undergoing thoracic surgery. One-lung ventilation (OLV) is essential for thoracic surgery but can cause lung injury. While standard care often uses fixed ventilation parameters, this study investigates whether personalizing Positive End-Expiratory Pressure (PEEP) to achieve the lowest driving pressure can reduce the incidence of postoperative pulmonary complications (PPCs) within 7 days after surgery.

Participants needed: 352
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Aerospace Center HospitalUpdated: Feb 4, 2026Locations: 1
Eligibility criteria

Age 18 to 75 years. [+5]

Pregnancy or breastfeeding. [+8]

Status: Not yet recruiting

Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium

This randomized controlled trial evaluates the efficacy of a proactive Goal-Directed Temperature Management (GDTM) protocol in reducing postoperative delirium among patients undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for pseudomyxoma peritonei. CRS-HIPEC presents a unique physiological challenge characterized by a biphasic thermal trajectory: potential hypothermia during extensive surgery followed by rapid iatrogenic hyperthermia during perfusion. This study compares a standardized GDTM strategy-which incorporates strict normothermia maintenance and anticipatory pre-cooling prior to perfusion-against standard reactive thermal management. The primary objective is to determine if optimized thermoregulation can attenuate thermal variability and improve early neurocognitive recovery.

Participants needed: 174
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Aerospace Center HospitalUpdated: Jan 30, 2026Locations: 1
Eligibility criteria

Adult patients (aged 18-80 years).

Known diagnosis of dementia, major neurocognitive disorder, or severe psychiatri...